Active, Not Recruiting
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
NCT04287829
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands